Shopping Cart 0
Cart Subtotal
USD 0

Vericel Corp (VCEL) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Vericel Corp (VCEL)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Vericel Corp (Vericel) develops and markets advanced cell therapies for sports medicine and severe burn domains. Its major products include MACI (autologous cultured chondrocytes on porcine collagen membrane) for the treatment of cartilage defects; and Epicel cultured epidermal autografts for skin replacement. The company is also developing ixmyelocel-T technology, a patient-specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy (DCM). It has manufacturing facilities in Cambridge, Massachusetts; Ann Harbour, Michigan and Kastrup, Denmark. The company sells its products through cell therapy specialists. Vericel is headquartered in Cambridge, Massachusetts, the US.

Vericel Corp Key Recent Developments

May 07,2019: Vericel reports first quarter 2019 financial results and raises full year 2019 revenue guidance

Feb 26,2019: Vericel announces fourth quarter and full-year 2018 financial results

Aug 20,2018: Vericel names Jonathan Hopper as chief medical officer

Aug 06,2018: Vericel Reports Record Second Quarter Revenues of USD 19.0 Million and Raises Full Year 2018 Revenue Guidance

May 08,2018: Vericel Reports First Quarter 2018 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Vericel Corp-Key Facts

Vericel Corp-Key Employees

Vericel Corp-Key Employee Biographies

Vericel Corp-Major Products and Services

Vericel Corp-History

Vericel Corp-Company Statement

Vericel Corp-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Vericel Corp-Business Description

Product Category: Carticel and MACI

Performance

Product Category: Epicel

Overview

Performance

Product Category: License Revenue

Overview

Performance

Product Category: MACI

Overview

R&D Overview

Vericel Corp-Corporate Strategy

Vericel Corp-SWOT Analysis

SWOT Analysis-Overview

Vericel Corp-Strengths

Vericel Corp-Weaknesses

Vericel Corp-Opportunities

Vericel Corp-Threats

Vericel Corp-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Vericel Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Vericel Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

Vericel Corp, Recent Deals Summary

Section 5-Company's Recent Developments

May 07, 2019: Vericel reports first quarter 2019 financial results and raises full year 2019 revenue guidance

Feb 26, 2019: Vericel announces fourth quarter and full-year 2018 financial results

Aug 20, 2018: Vericel names Jonathan Hopper as chief medical officer

Aug 06, 2018: Vericel Reports Record Second Quarter Revenues of USD 19.0 Million and Raises Full Year 2018 Revenue Guidance

May 08, 2018: Vericel Reports First Quarter 2018 Financial Results

Mar 05, 2018: Vericel Reports Fourth Quarter and Year End 2017 Financial Results and Provides Full Year 2018 Financial Guidance

Feb 14, 2018: The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor Day

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Vericel Corp, Performance Chart (2014-2018)

Vericel Corp, Ratio Charts

Vericel Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Vericel Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Vericel Corp, Key Facts

Vericel Corp, Key Employees

Vericel Corp, Key Employee Biographies

Vericel Corp, Major Products and Services

Vericel Corp, History

Vericel Corp, Other Locations

Vericel Corp, Subsidiaries

Vericel Corp, Key Competitors

Vericel Corp, Ratios based on current share price

Vericel Corp, Annual Ratios

Vericel Corp, Annual Ratios (Cont...1)

Vericel Corp, Interim Ratios

Vericel Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Vericel Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

Vericel Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Vericel Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

TiGenix Inc

Miltenyi Biotec Inc

Geistlich Pharma North America Inc

Cytori Therapeutics Inc

Compass Biomedical Inc

Avita Medical Americas LLC

AdiSave Inc

Vericel Corp (VCEL)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Vericel Corp (Vericel) develops and markets advanced cell therapies for sports medicine and severe burn domains. Its major products include MACI (autologous cultured chondrocytes on porcine collagen membrane) for the treatment of cartilage defects; and Epicel cultured epidermal autografts for skin replacement. The company is also developing ixmyelocel-T technology, a patient-specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy (DCM). It has manufacturing facilities in Cambridge, Massachusetts; Ann Harbour, Michigan and Kastrup, Denmark. The company sells its products through cell therapy specialists. Vericel is headquartered in Cambridge, Massachusetts, the US.

Vericel Corp Key Recent Developments

May 07,2019: Vericel reports first quarter 2019 financial results and raises full year 2019 revenue guidance

Feb 26,2019: Vericel announces fourth quarter and full-year 2018 financial results

Aug 20,2018: Vericel names Jonathan Hopper as chief medical officer

Aug 06,2018: Vericel Reports Record Second Quarter Revenues of USD 19.0 Million and Raises Full Year 2018 Revenue Guidance

May 08,2018: Vericel Reports First Quarter 2018 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Vericel Corp-Key Facts

Vericel Corp-Key Employees

Vericel Corp-Key Employee Biographies

Vericel Corp-Major Products and Services

Vericel Corp-History

Vericel Corp-Company Statement

Vericel Corp-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Vericel Corp-Business Description

Product Category: Carticel and MACI

Performance

Product Category: Epicel

Overview

Performance

Product Category: License Revenue

Overview

Performance

Product Category: MACI

Overview

R&D Overview

Vericel Corp-Corporate Strategy

Vericel Corp-SWOT Analysis

SWOT Analysis-Overview

Vericel Corp-Strengths

Vericel Corp-Weaknesses

Vericel Corp-Opportunities

Vericel Corp-Threats

Vericel Corp-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Vericel Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Vericel Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

Vericel Corp, Recent Deals Summary

Section 5-Company's Recent Developments

May 07, 2019: Vericel reports first quarter 2019 financial results and raises full year 2019 revenue guidance

Feb 26, 2019: Vericel announces fourth quarter and full-year 2018 financial results

Aug 20, 2018: Vericel names Jonathan Hopper as chief medical officer

Aug 06, 2018: Vericel Reports Record Second Quarter Revenues of USD 19.0 Million and Raises Full Year 2018 Revenue Guidance

May 08, 2018: Vericel Reports First Quarter 2018 Financial Results

Mar 05, 2018: Vericel Reports Fourth Quarter and Year End 2017 Financial Results and Provides Full Year 2018 Financial Guidance

Feb 14, 2018: The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor Day

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Vericel Corp, Performance Chart (2014-2018)

Vericel Corp, Ratio Charts

Vericel Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Vericel Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Vericel Corp, Key Facts

Vericel Corp, Key Employees

Vericel Corp, Key Employee Biographies

Vericel Corp, Major Products and Services

Vericel Corp, History

Vericel Corp, Other Locations

Vericel Corp, Subsidiaries

Vericel Corp, Key Competitors

Vericel Corp, Ratios based on current share price

Vericel Corp, Annual Ratios

Vericel Corp, Annual Ratios (Cont...1)

Vericel Corp, Interim Ratios

Vericel Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Vericel Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

Vericel Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Vericel Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

TiGenix Inc

Miltenyi Biotec Inc

Geistlich Pharma North America Inc

Cytori Therapeutics Inc

Compass Biomedical Inc

Avita Medical Americas LLC

AdiSave Inc